PharmaCyte Biotech's total assets for Q3 2025 were $43.83M, a decrease of -20.45% from the previous quarter. PMCB total liabilities were $3.58M for the fiscal quarter, a -69.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.